Get all your news in one place.
100's of premium titles.
One app.
Start reading
Al Jazeera
Al Jazeera
Health

New trials show increased survival rates for a range of cancers

The treatment osimertinib was shown to halve the risk of death from a certain type of lung cancer [File: Getty Images]

Scientists have convened in the United States city of Chicago for a meeting of the American Society of Clinical Oncology (ASCO), the world’s biggest gathering of experts on cancer.

At the annual event, which wraps up on Tuesday, doctors and researchers revealed several studies that showed increased survival rates for people living with serious stages of the disease, including for lung and brain cancer.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.